Other OTC - Delayed Quote USD

OWC Pharmaceutical Research Corp. (OWCP)

0.0000 0.0000 (0.00%)
At close: April 22 at 1:12 PM EDT
Key Events
Loading Chart for OWCP
DELL
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0001
  • Volume 29,000
  • Avg. Volume 0
  • Market Cap (intraday) 497
  • Beta (5Y Monthly) -233.45
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. It develops cannabis-based medical products for the treatment of various conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder, chronic pain, and fibromyalgia. The company is also involved in developing cannabis soluble tablet delivery system. In addition, it provides consulting services to companies and governmental agencies related to international medical cannabis protocols and regulations. The company was formerly known as Dynamic Applications Corp. and changed its name to OWC Pharmaceutical Research Corp. in December 2014. OWC Pharmaceutical Research Corp. was founded in 2008 and is based in Ramat Gan, Israel.

www.owcpharma.com

9

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: OWCP

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

OWCP
99.00%
S&P 500
6.92%

1-Year Return

OWCP
99.00%
S&P 500
25.26%

3-Year Return

OWCP
99.99%
S&P 500
22.00%

5-Year Return

OWCP
100.00%
S&P 500
74.29%

Compare To: OWCP

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: OWCP

Valuation Measures

Annual
As of 4/27/2024
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    -0.01

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -64.48%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -2.29M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.47M

  • Total Debt/Equity (mrq)

    15.36%

  • Levered Free Cash Flow (ttm)

    -883.89k

Company Insights: OWCP

People Also Watch